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Abstract 
The intestinal microflora has an important impact on life and has important implications for 
health in every human being. Probiotics are life micro-organisms that might have, after 
consumption in specific quantities, an impact on human health. The mechanisms by which 
probiotics confer their health effects in general terms will be discussed. Specific reports on 
the probiotics Bifidobacterium animalis and Lactobacillus paracasei consistently contain 
statements that both shortterm and long-term feeding of these probiotics to children aged 1-3 
years, infants aged 0-12 months, and even to pre-term infants is not associated with 
differences in growth, stooling/ defecation patterns, behavioural aspects or history of illness 
compared to control groups. With regard to beneficial clinical effects with probiotics in 
general, the consistent and world-wide emergence of data that indicate beneficial clinical 
effects of some probiotic strains like Bifidobacterium animalis and Lactobacillus paracasei in 
infants and children cannot be ignored. Especially their potential benefit in preventing or 
ameliorating gastrointestinal inflammation and diarrhoea appears to be a realistic notion. 
First, inflammatory effects should translate into enhanced immunity, diminishment of 
existing unresponsive inflammation and correction of existing immunological defects. 
Second, enzymatic activities of probiotic bacteria might correct functional deficits induced by 
infectious diseases. Although it is unclear what the relevance is at this moment in time, some 
probiotics strains clearly show immune modulating effects in infants. 
  
 
